Skip to main content
Top
Published in: Journal of Public Health 1/2021

01-02-2021 | Allergic Rhinitis | Review Article

To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment

Authors: Andrea Stippler, Niels Eckstein, Elmar Kroth

Published in: Journal of Public Health | Issue 1/2021

Login to get access

Abstract

Background

The consent of community pharmacists is an important factor for the successful implementation of Rx-to-OTC switches but is not part of the official reclassification procedure in Germany.

Objective

The aim was to identify potential switch candidates and indications in addition to a basic assessment of new switches in Germany.

Setting

The survey was distributed via the online survey tool of the pharmaceutical journal “Deutsche Apotheker Zeitung” within the period from 20 September to 8 October 2017.

Methods

The survey comprised 17 questions. Besides some basic parameters, the questionnaire included a list of proposals for new switch candidates, a vote on the general support as well as economic and health professional expectations regarding further switches.

Main outcome measure

The highest consent scores were obtained for second-generation antihistamines for treatment of hay fever such as desloratadine, fexofenadine and levocetirizine.

Results

Nine hundred forty pharmacy employees participated in the survey. Beside second-generation antihistamines, there are further preferred switches for nasal glucocorticoids, proton pump inhibitors, ocular antibiotics and emergency kits for acute dyspnoea.

Conclusion

Pharmacists strongly welcome further switches. This leads to high acceptance rates, especially for a switch of desloratadine, as this was the most named active ingredient possible for a switch within the survey.

Impact of findings on practice statements

The outcome of this survey can support pharmaceutical companies in decision-making about which active substances they should submit a switch application for. Additionally, this helps fulfil patient needs, because pharmacists know best what is beneficial for patient self-care. In addition, all other actors involved in this process can see what is required and can rethink their position regarding further switches.
Literature
go back to reference Kunz D, Eckstein N (2017)OTC-switch von Mometason und Fluticason [OTC-switch of mometsone and fluticasone]. Pharm Ztg 162:42–47 Kunz D, Eckstein N (2017)OTC-switch von Mometason und Fluticason [OTC-switch of mometsone and fluticasone]. Pharm Ztg 162:42–47
go back to reference Lalonde L, Tsuyuki RT, Landry E, Taylor J (2012) Results of a national survey on OTC medicines, part 2: do pharmacists support switching prescription agents to over-the-counter status? Can Pharm J 145:73–76CrossRef Lalonde L, Tsuyuki RT, Landry E, Taylor J (2012) Results of a national survey on OTC medicines, part 2: do pharmacists support switching prescription agents to over-the-counter status? Can Pharm J 145:73–76CrossRef
go back to reference Metzger A, Eckstein N (2016) Hemmschwelle deutlich reduziert: Umfrage zur Abgabe der "Pille danach" in Apotheken [Inhibitor clamp significantly reduced, survey on the delivery of the "morning after pill" in pharmacies]. Deutsche Apotheker Zeitung 156:56–60 Metzger A, Eckstein N (2016) Hemmschwelle deutlich reduziert: Umfrage zur Abgabe der "Pille danach" in Apotheken [Inhibitor clamp significantly reduced, survey on the delivery of the "morning after pill" in pharmacies]. Deutsche Apotheker Zeitung 156:56–60
go back to reference Powis MG, Rogers PJ, Wood SM (1996) United Kingdom community pharmacists' views on recent 'POM-to-P' switched medicines. J Soc Adm Pharm 13:188–197 Powis MG, Rogers PJ, Wood SM (1996) United Kingdom community pharmacists' views on recent 'POM-to-P' switched medicines. J Soc Adm Pharm 13:188–197
go back to reference Stippler A, Kroth E, Eckstein N (2018a) To switch or not to switch?: Erste deutschlandweite Umfrage zum OTC-Bedarf aus Sicht der Apothekerschaft [To switch or not to switch? First Germany-wide survey on demand of OTC from the pharmacy perspective]. Deutsche Apotheker Zeitung 158:74–81 Stippler A, Kroth E, Eckstein N (2018a) To switch or not to switch?: Erste deutschlandweite Umfrage zum OTC-Bedarf aus Sicht der Apothekerschaft [To switch or not to switch? First Germany-wide survey on demand of OTC from the pharmacy perspective]. Deutsche Apotheker Zeitung 158:74–81
go back to reference Stippler A, Voltz A, Kroth E, Eckstein N (2018b)OTC-switches Sind option für viele Ärzte [OTC switches are an option for many doctors]. Ärzte Zeitung, p 74–81 Stippler A, Voltz A, Kroth E, Eckstein N (2018b)OTC-switches Sind option für viele Ärzte [OTC switches are an option for many doctors]. Ärzte Zeitung, p 74–81
Metadata
Title
To switch or not to switch—first Germany-wide study from the perspective of pharmacists in the European environment
Authors
Andrea Stippler
Niels Eckstein
Elmar Kroth
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Public Health / Issue 1/2021
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-019-01101-4

Other articles of this Issue 1/2021

Journal of Public Health 1/2021 Go to the issue